Organic Chemistry and Pharmaceutical Laboratory, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Rua Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.
Interdisciplinary Centre of Marine and Environmental Research (CIIMAR/CIMAR), University of Porto, Rua dos Bragas 289, 4050-123 Porto, Portugal.
Pharmaceuticals (Basel). 2016 Jun 29;9(3):37. doi: 10.3390/ph9030037.
Even after a century, heparin is still the most effective anticoagulant available with few side effects. The poor oral absorption of heparins triggered the search for strategies to achieve oral bioavailability since this route has evident advantages over parenteral administration. Several approaches emerged, such as conjugation of heparins with bile acids and lipids, formulation with penetration enhancers, and encapsulation of heparins in micro and nanoparticles. Some of these strategies appear to have potential as good delivery systems to overcome heparin's low oral bioavailability. Nevertheless, none have reached the market yet. Overall, this review aims to provide insights regarding the oral bioavailability of heparin.
即使过去了一个世纪,肝素仍然是最有效的抗凝剂之一,副作用较少。肝素口服吸收差,这促使人们寻找策略来提高其口服生物利用度,因为与肠外给药相比,这种途径具有明显的优势。已经出现了几种方法,例如将肝素与胆汁酸和脂质缀合、与穿透增强剂一起配方,以及将肝素封装在微球和纳米球中。其中一些策略似乎具有作为良好的递送系统的潜力,可以克服肝素的低口服生物利用度。然而,目前还没有一种方法能够上市。总的来说,本综述旨在提供肝素口服生物利用度方面的见解。